Methimazole Dosing for Hyperthyroidism
Start methimazole at 10-20 mg once daily for adults with newly diagnosed overt hyperthyroidism, then titrate down to a maintenance dose of 5-10 mg daily once euthyroid. 1, 2
Starting Dose Algorithm
The initial dose should be matched to disease severity:
- Mild hyperthyroidism: 10-15 mg daily 1, 2
- Moderately severe hyperthyroidism: 30-40 mg daily 2
- Severe hyperthyroidism: 60 mg daily 2
Administer as a single daily dose - methimazole has a long enough half-life that once-daily dosing is equally effective as divided doses and improves adherence 1. The FDA label technically states "3 divided doses at 8-hour intervals" 2, but the strongest guideline evidence from the American Thyroid Association/American Association of Clinical Endocrinologists clearly supports once-daily administration 1.
Maintenance Dose
Once thyroid function normalizes (typically within 4-8 weeks), reduce to a maintenance dose of 5-10 mg daily 1. The goal is to use the lowest dose that maintains euthyroidism.
Monitor thyroid function tests monthly initially, then every 6-8 weeks once stable. A rising TSH indicates the need to reduce the methimazole dose 2.
Critical Safety Considerations
Before starting methimazole, obtain baseline labs: complete blood count with differential and liver function tests (transaminases, bilirubin) 1. This is essential because low white counts occur in autoimmune diseases and African Americans, and abnormal liver enzymes are common in thyrotoxicosis itself - you need baseline values for comparison.
Warn patients to stop methimazole immediately and call if they develop: fever, sore throat, rash, jaundice, pale stools, dark urine, joint pain, abdominal pain, or severe fatigue 1. These may signal agranulocytosis (0.2-0.5% risk) or hepatotoxicity. Document this counseling in writing 1.
Important Pitfalls to Avoid
Do NOT use "block-and-replace" therapy (high-dose methimazole plus levothyroxine) - this increases adverse effects without improving outcomes 1. Always use the titration approach with the lowest effective dose.
Do NOT exceed 20 mg daily as a starting dose in most patients - agranulocytosis risk is dose-dependent 3. The exception is severe hyperthyroidism where up to 60 mg may be necessary initially 2.
Methimazole is preferred over propylthiouracil in virtually all patients except: first trimester pregnancy, thyroid storm, or patients with minor methimazole reactions who refuse radioiodine/surgery 1. PTU carries unacceptable hepatotoxicity risk including fulminant hepatic necrosis requiring transplantation 1.
Special Populations
Pregnancy: Switch to propylthiouracil in first trimester due to methimazole embryopathy risk (choanal/esophageal atresia, aplasia cutis). Return to methimazole in second trimester due to PTU hepatotoxicity risk 1.
Pediatrics: Use 0.2-0.5 mg/kg daily initially (typical whole tablet doses: 1-5 years = 2.5-5 mg/day; 5-10 years = 5-10 mg/day; 10-18 years = 10-20 mg/day), then reduce by 50% once euthyroid 1.
Duration of Therapy
Standard treatment duration is 12-18 months 4. However, recent high-quality evidence shows that long-term continuation (≥60 months) of low-dose methimazole (2.5-5 mg daily) substantially reduces relapse rates from ~50% with conventional courses to <20% with extended therapy, with minimal adverse effects 5, 6, 7. This should be considered in patients who achieve stable euthyroidism on low-dose therapy, particularly those under age 40 who have higher relapse risk 7.